Tonix Pharm Holdings (TNXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,208 | -5,164 | -10,884 | -7,177 | -4,087 |
| Depreciation Amortization | 9 | 4 | 17 | 12 | 8 |
| Accounts payable and accrued liabilities | 754 | 635 | -60 | 160 | 636 |
| Other Working Capital | -376 | -65 | 582 | 873 | 1,098 |
| Other Operating Activity | 1,058 | 526 | 1,828 | 1,146 | 222 |
| Operating Cash Flow | $-9,763 | $-4,064 | $-8,517 | $-4,986 | $-2,123 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -35 | -2 | -15 | -8 | N/A |
| Other Investing Activity | -72 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-107 | $-2 | $-15 | $-8 | $0 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 280 | 280 | 200 |
| Common Stock Issued | 45,543 | 45,412 | 14,670 | 10,349 | 307 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -101 |
| Financing Cash Flow | $45,543 | $45,412 | $14,950 | $10,629 | $406 |
| Exchange Rate Effect | -5 | -1 | -1 | N/A | 0 |
| Beginning Cash Position | 8,202 | 8,202 | 1,785 | 1,785 | 1,785 |
| End Cash Position | 43,870 | 49,547 | 8,202 | 7,420 | 68 |
| Net Cash Flow | $35,668 | $41,345 | $6,417 | $5,635 | $-1,717 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,763 | -4,064 | -8,517 | -4,986 | -2,123 |
| Capital Expenditure | -35 | -2 | -15 | -8 | 0 |
| Free Cash Flow | -9,798 | -4,066 | -8,532 | -4,994 | -2,123 |